• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • UCB Pharma, Cambridge, MA, USA, Cambridge, MA

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 2 of 2

  • Page:
  • 1

Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis

Author:Weiss, Michael D.   Bresch, Saskia   Freimer, Miriam   Hewamadduma, Channa   Juntas-Morales, Raul   Leite, M. Isabel   Maniaol, Angelina   Masuda, Masayuki   Sivakumar, Kumaraswamy   Zajda, Malgorzata   Boroojerdi, Babak   Duda, Petra W.   De La Borderie, Guillemette   Howard Jr., James F.   

Session Name:P1: Autoimmune Neurology: Myasthenia Gravis  

Topic:Autoimmune Neurology  

Program Number:P1.006  

Author Institution:University of Washington Medical Center, Department of Neurology, Seattle, WA  Centre Hospitalier Universitaire de Nice, Nice, France  The Ohio State University, Columbus, OH  University of Sheffield, Sheffield, United Kingdom  Vall d’Hebron University Hospital, Barcelona, Spain  Nuffield Department of Clinical Neurosciences - University of Oxford, Oxford, United Kingdom  Oslo University Hospital, Oslo, Norway  Tokyo Medical University, Tokyo, Japan  University of Arizona, School of Medicine, Neuromuscular Clinic and Research Center, Phoenix, AZ  Medical University of Warsaw, Warsaw, Poland  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Cambridge, MA, USA, Cambridge, MA  UCB Pharma, Brussels, Belgium, Saint Cloud, France  The University of North Carolina, Chapel Hill, NC  

  • View Abstract
  • View Disclosure

RAISE-XT: An interim analysis of safety and efficacy in an open-label extension study of zilucoplan in patients with myasthenia gravis

Author:Freimer, Miriam   Leite, M. Isabel   Genge, Angela   Hussain, Yessar   Kaminski, Henry J.   Mantegazza, Renato   Utsugisawa, Kimiaki   Vu, Tuan   Duda, Petra W.   Boroojerdi, Babak   Vanderkelen, Mark   Lowcock, Romana   Howard Jr., James F.   

Session Name:P1: Autoimmune Neurology: Myasthenia Gravis  

Topic:Autoimmune Neurology  

Program Number:P1.007  

Author Institution:The Ohio State University Wexner Medical Center, Columbus, OH  University of Oxford, Oxford, United Kingdom  The Montreal Neurological Institute, Montreal, QC, Canada  The University of Texas at Austin, Austin, TX  George Washington University, Washington, DC  Fondazione Istituto Neurologico, Milan, Italy  Hanamaki General Hospital, Hanamaki, Japan  University of South Florida Morsani College of Medicine, Tampa, FL  UCB Pharma, Cambridge, MA, USA, Cambridge, MA  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Braine L'Alleud, Belgium, Braine L'Alleud, Belgium  UCB Pharma, Slough, UK, Slough, United Kingdom  The University of North Carolina at Chapel Hill, Chapel Hill, NC  

  • View Abstract
  • View Disclosure

Displaying 1 - 2 of 2

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com